it is paramount that we address both cholesterol risk and inflammation to reduce the risk of a heart attack or stroke.
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and reimbursement.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It's part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.
The Illinois-based health system is teaming up with the analytics company to launch a genomics program, which will focus on predicting the risk of illness and outcomes among patients. It will also provide free genetic testing to low-income patients in an effort to increase access to genomic care.
Heartbeat Health, a digital health startup to help patients manage heart disease, raised $8.2 million in series A funding. The platform offers telehealth visits and helps patients keep track of their heart health by pulling in metrics from wearables and other devices.
The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
While the development of renal denervation technologies stalled after a failed Medtronic study in 2014, recent positive research results have led to increasing interest - and investment - in the space.
The new Japanese reimbursement policy will go into effect on Dec. 1 and follows positive coverage decisions by Medicare and the United Kingdom’s National Health Services.
The tool harnesses Mayo Clinic's cardiovascular database and expertise in heart disease screening combined with Eko's cardiac monitoring platform.
Apple Watch's entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
Color Genomics' latest test highlights the quandary of genetic testing colliding with value-based care: Is the push to test taking preventive medicine in the wrong direction?
In a study published in JAMA, researchers at UCSF used an innovative protein measurement assay developed by healthcare technology company SomaLogic to detect 1,130 different proteins in the plasma of nearly 2,000 individuals already diagnosed with coronary heart disease.
The HeartLight system allows electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with high procedural flexibility.
The Venus P-valve pulmonary replacement has already been implanted in more than 40 patients, and the current goal is to win CE Mark approval. They will reportedly be enrolling patients to accomplish this in the early half of the year.